FDA Drug Recalls

Recalls / Class II

Class IID-887-2013

Product

Propofol Injectable Emulsion, 1%, 1 g/100 mL (10 mg/mL), 100 mL, Single patient infusion vial, RX only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-24; Propofol Injectable Emulsion, 500 mg/50 mL, 50 mL, Single patient infusion vial, RX only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-33

Brand name
Propofol
Generic name
Propofol
Active ingredient
Propofol
Route
Intravenous
NDCs
0409-4699, 0409-6010
FDA application
ANDA077908
Affected lot / code info
Lot 07-950-DJ Exp. Date 1JUL2013, 10-101-DJ Exp. Date 1OCT2013, and 10-102-DJ Exp. Date 1OCT2013

Why it was recalled

Presence of Particulate Matter; single visible particulate was identified during a retain sample inspection identified as stainless steel

Recalling firm

Firm
Hospira Inc.
Manufacturer
Hospira, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
275 N Field Dr, Lake Forest, Illinois 60045-2579

Distribution

Quantity
94,110 vials
Distribution pattern
Nationwide

Timeline

Recall initiated
2013-05-25
FDA classified
2013-08-13
Posted by FDA
2013-08-21
Terminated
2014-09-18
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-887-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.